Deaths are continuing to reach extraordinarily high numbers and have now soared to 26 percent higher than pre-pandemic levels, new data has revealed.
A new study by U.K. researchers reveals that deaths have been soaring in England and Wales during January 2023.
In the week ending January 13, there were 17,381 deaths in England and Wales alone.
The figure is 2,837 or 19.5% above the five-year average.
However, the five-year average is already higher than normal due to the early 2021 Covid wave.
Compared to the pre-pandemic five-year average of 13,822, deaths are now 3,559 or 25.7% above average.
There were 922 deaths with Covid registered on the death certificate, of which 654 were registered as due to Covid as the underlying cause.
This leaves 2,183 excess deaths from a different underlying cause.
Since the wave of excess non-Covid deaths began in April the total now stands at 34,691.
Previous data has revealed that excess deaths started to soar around the spring and fall of last year when governments rolled out their “booster” campaigns.
The U.K., like many other nations around the world, has suffered a staggering rise in the number of heart attacks and related deaths.
Yet the British government’s Chief Medical Officer Chris Whitty has recently claimed that 5,170 deaths in men aged 50-64 could have been helped by heart medications that were missed during the pandemic.
Health Secretary Steve Barclay agreed, saying that “we know from the data that there are more 50 to 64-year-olds with cardiovascular issues.”
Barclay blames the trend on “the result of delays in that age group seeing a GP because of the pandemic and in some cases, not getting statins for hypertension in time.”
The British Heart Foundation published research earlier this month which made similar claims.
However, such claims were dismissed by Dr. Carl Heneghan, the Professor of Evidence-based Medicine at Oxford University.
Heneghan and his colleague Dr. Tom Jefferson wrote that the extra cardiovascular disease deaths cannot be accounted for by a fall in drug treatment or drop in risk monitoring, “given the lack of evidence of an effect.”
In making this assessment, they relied in part on a major recent study reviewing the trial data on statins and concluding that the benefits of statins were minimal and most of the trial participants who took statins derived no clinical benefit.
Dr. Heneghan and Dr. Jefferson also noted that the claimed reduction in prescriptions appears to be illusory, with rises and falls well within normal levels.
Meanwhile, health experts in Japan have been investigating links between the increase in deaths, particularly from cardiovascular causes, and mRNA shots.
In Japan, Covid deaths have actually been increasing after each booster campaign.
However, public health authorities have noted that the “Covid” deaths now are more likely to be test-positive deaths from cardiovascular problems rather than classic respiratory deaths.
There are also many non-Covid excess deaths in Japan, largely from heart problems.
With respect to myocarditis in particular, a recent analysis by HART notes that elevated myocarditis admissions began with the vaccine rollout and did not occur in 2020.
Researchers suggest that the data indicates a limited role for the virus and a major role for the vaccines.